Skip to main content
Top
Published in: BMC Health Services Research 1/2016

Open Access 01-12-2016 | Research article

Quantitative evaluation of essential medicines lists: the South African case study

Authors: Velisha Ann Perumal-Pillay, Fatima Suleman

Published in: BMC Health Services Research | Issue 1/2016

Login to get access

Abstract

Background

The South African (SA) health system has employed an Essential Medicines List (EML) with Standard Treatment Guidelines (STGs) since 1996. To date no studies have reported the changes in SA STG/EMLs. This study describes these changes over time (1996–2013) and compares latest SA STG/EMLs with the latest World Health Organization (WHO) Model EMLs to assess alignment of these lists.

Methods

A quantitative evaluation of SA STGs/EMLs at 2 levels of healthcare was performed to assess changes in the number and ratio of molecules, dosage forms, and additions and deletions of medicines. The most recent WHO EMLs (18th list, 4th list for children) and 2012 priority life-saving medicines for women and children (PMWC) list were compared to the most recent available SA STG/EMLs (Primary Health Care (PHC 2008), Adult Hospital 2012, and Paediatric Hospital 2013) at the time of the research.

Results

The number of molecules over the years increased for PHC STG/EMLs but decreased slightly for Adult and Paediatric hospital STG/EMLs. The most additions and deletions over time occurred in the Adult hospital level STG/EML (27 in 2006 and 44 in 2012). A comparison between the most recent SA STG/EMLs and WHO Model EML (18th list) showed that a total of 112 medicines were absent on all SA STG/EMLs. A comparison of medicines for children between the 2013 SA Paediatric Hospital level STG/EML and PMWC indicated that these lists were somewhat aligned for most conditions as only 3 of 14 medicines and 11 of 20 vaccines were absent from SA STG/EMLs.

Conclusion

This is the first study in SA to investigate changes in National EMLs over time in relation to molecules, dosage forms and therapeutic classes. It is also the first to compare the latest SA STG/EMLs to the WHO Model lists. The results therefore provide insight into the trends and SA STG/EML processes over time.
Footnotes
1
This reference refers to the medicine procurement list which is constantly updated and the most recent master procurement list was reflected.
 
Literature
2.
go back to reference Quick JD, Hogerzeil HV, Velasquez G, Rago L. Twenty-five years of essential medicines. Bull World Health Organ. 2002;80(11):913–4.PubMedPubMedCentral Quick JD, Hogerzeil HV, Velasquez G, Rago L. Twenty-five years of essential medicines. Bull World Health Organ. 2002;80(11):913–4.PubMedPubMedCentral
8.
go back to reference Hill SR, Gray A, Webber M. Setting standards for essential children’s medicines. Bull World Health Organ. 2007;85(9):649–732.CrossRef Hill SR, Gray A, Webber M. Setting standards for essential children’s medicines. Bull World Health Organ. 2007;85(9):649–732.CrossRef
13.
go back to reference Laing R, Waning B, Gray A, Ford N, ‘t Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003;361:1723–9.CrossRefPubMed Laing R, Waning B, Gray A, Ford N, ‘t Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003;361:1723–9.CrossRefPubMed
14.
go back to reference Hospital level Adults Standard Treatment Guidelines and Essential Drugs List 2006. The National Department of Health. South Africa; 2006 Hospital level Adults Standard Treatment Guidelines and Essential Drugs List 2006. The National Department of Health. South Africa; 2006
15.
go back to reference Hospital level Adults Standard Treatment Guidelines and Essential Drugs List 2012. The National Department of Health. South Africa; 2012 Hospital level Adults Standard Treatment Guidelines and Essential Drugs List 2012. The National Department of Health. South Africa; 2012
19.
go back to reference Georgeu D, Colvin CJ, Lewin S, Fairall L, O Bachmann M, Uebel K, Zwarenstein M, Draper B, Bateman ED. Implementing nurse-initiated and managed antiretroviral treatment (NIMART) in South Africa: a qualitative process evaluation of the STRETCH trial. Implement Sci. 2012. doi:10.1186/1748-5908-7-66.PubMedPubMedCentral Georgeu D, Colvin CJ, Lewin S, Fairall L, O Bachmann M, Uebel K, Zwarenstein M, Draper B, Bateman ED. Implementing nurse-initiated and managed antiretroviral treatment (NIMART) in South Africa: a qualitative process evaluation of the STRETCH trial. Implement Sci. 2012. doi:10.​1186/​1748-5908-7-66.PubMedPubMedCentral
23.
go back to reference Vaccinator’s manual “Immunisation that works” expanded programme on immunisation in South Africa (EPI-SA). The National Department of Health, South Africa; 2012 Vaccinator’s manual “Immunisation that works” expanded programme on immunisation in South Africa (EPI-SA). The National Department of Health, South Africa; 2012
24.
go back to reference Lalloo R, Smith MJ, Myburgh NG, Solanki GC. Access to health care in South Africa – the influence of race and class. SAMJ. 2004;94(8):639–42. PMID:15352587.PubMed Lalloo R, Smith MJ, Myburgh NG, Solanki GC. Access to health care in South Africa – the influence of race and class. SAMJ. 2004;94(8):639–42. PMID:15352587.PubMed
25.
26.
go back to reference Kadic AJ, Zanic M, Skaricic N, Marusic A. Using the WHO essential medicines list to assess the appropriateness of insurance coverage decisions: a case study of the Croatian national medicine reimbursement list. PLoS One. 2014. doi:10.1371/journal.pone.0111474. Kadic AJ, Zanic M, Skaricic N, Marusic A. Using the WHO essential medicines list to assess the appropriateness of insurance coverage decisions: a case study of the Croatian national medicine reimbursement list. PLoS One. 2014. doi:10.​1371/​journal.​pone.​0111474.
27.
go back to reference Zhang M, Liu J, Lu J, Zhang S. Exploring impacts of the revised EML ans associated policies. IMS Consuting Group. 2013. Zhang M, Liu J, Lu J, Zhang S. Exploring impacts of the revised EML ans associated policies. IMS Consuting Group. 2013.
28.
go back to reference Lu Y, Laing R. Comparison of the Chinese National Essential Medicines Lists with WHO Essential Medicines Model List. Utrecht: World Health Organization Winter meeting; 2010. Lu Y, Laing R. Comparison of the Chinese National Essential Medicines Lists with WHO Essential Medicines Model List. Utrecht: World Health Organization Winter meeting; 2010.
29.
go back to reference Tejani AH, Wertheimer A. International variations in essential medication lists. Innovations in Pharmacy. 2014;5(1):1–11. Tejani AH, Wertheimer A. International variations in essential medication lists. Innovations in Pharmacy. 2014;5(1):1–11.
Metadata
Title
Quantitative evaluation of essential medicines lists: the South African case study
Authors
Velisha Ann Perumal-Pillay
Fatima Suleman
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2016
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1937-x

Other articles of this Issue 1/2016

BMC Health Services Research 1/2016 Go to the issue